The aim of that technical working group is to review the proposals put forward by Member States and manufacturers for COVID-19 rapid antigen tests to be included in the EU common list of rapid antigen tests agreed by the Health Security Committee [https://ec.europa.eu/health/system/files/2022-01/covid-19_rat_common-list_en.pdf]. In accordance with Article 3(1), point (b), of Regulation (EU) 2021/953, only COVID-19 rapid antigen tests included in that list can form the basis for the issuance of a test certificate in the EU Digital COVID Certificate format. The technical working group assesses these proposals against the criteria established by the Council Recommendation of 21 January 2021 [Council Recommendation of 21 January 2021 on a common framework for the use and validation of rapid antigen tests and the mutual recognition of COVID-19 test results in the EU (OJ C 24, 22.1.2021, p. 1).] as well as further criteria that the group agreed upon on 21 September 2021. One of the criteria agreed upon was an increased specificity rate of over 98 %.
Recital 4, Regulation (EU) 2022/256
In forcesince 22 Feb 2022
- celex=32021R0953